Bioinformatics News Jan 2008: bioinformatics, genomics, proteomics, microarray, etc.

Previous 1 2 3 4 5 Next

TOP2A FISH technique to test breast cancer recurrence approved by FDA
Every year the scientists make further steps to try and predict risk breast cancer recurrence. In planning treatment, doctors can use PCR tests like Oncotype DX or microarray tests like MammaPrint that predict breast cancer recurrence risk based on gene expression. (Wed, 16 Jan 2008 21:00:01 GMT)

Grant for Workflow Software
Developing tools to help scientists automate their scientific data management and analysis workflows is the aim of a new $1.7 million, three-year grant from the National Science Foundation to UC Davis, UC Santa Barbara and UC San Diego. (Wed, 16 Jan 2008 21:10:10 GMT)

Synthetic Genomics Inc. Appoints Chief Financial Officer
Synthetic Genomics Inc., a privately held company dedicated to developing and commercializing genomic-driven solutions to address global energy and environmental challenges, today announced the appointment of Chuck McBride as Executive Vice President and Chief Financial Officer, effective February 12, 2008. (Wed, 16 Jan 2008 21:39:53 GMT)

Study finds that blood test can gauge prostate cancer risk
WINSTON-SALEM, N.C. – New genomics research has found that a simple blood test can determine which men are likely to develop prostate cancer. (Wed, 16 Jan 2008 22:10:41 GMT)

Study Finds that Blood Test Can Gauge Prostate Cancer Risk
New genomics research has found that a simple blood test can determine which men are likely to develop prostate cancer. Researchers at Wake Forest University School of Medicine and colleagues found that five genetic variants previously associated with prostate cancer risk have a strong cumulative effect. (Wed, 16 Jan 2008 22:18:00 GMT)

New Tutorial Suite on SMART (Simple Modular Architecture Research Tool)
Comprehensive Tutorial on the SMART Bioinformatics Resource enables researchers to quickly and effectively use invaluable resource. (Thu, 17 Jan 2008 07:01:00 GMT)

Google rave in Fremont draws a crowd of techies
Excerpts from the blog The year is young, but so far the Seattle tech scene's biggest bash of 2008 was Tuesday night's open house/job fair... (Thu, 17 Jan 2008 08:23:19 GMT)

Genetics pioneer honored
Hopkins' McKusick is awarded prestigious Japan Prize, $470,000 Dr. Victor A. McKusick, a Johns Hopkins professor widely considered the father of medical genetics, has been awarded the prestigious Japan Prize in Medical Genetics and Genomics and the $470,000 that goes with it. (Thu, 17 Jan 2008 08:35:09 GMT)

Study Finds That Blood Test Can Gauge Prostate Cancer Risk
New genomics research has found that a simple blood test can determine which men are likely to develop prostate cancer. Researchers at Wake Forest University School of Medicine and colleagues found that five genetic variants previously associated with prostate cancer risk have a strong cumulative effect. (Thu, 17 Jan 2008 09:06:12 GMT)

A ''Yes/No'' Blood Test For Alzheimer's?
HOUSTON----For every person with Alzheimer's disease, there are many more--loved ones, healthcare providers, social workers, volunteers, and advocates--whose lives are directly or indirectly touched by this illness. (Thu, 17 Jan 2008 09:35:00 GMT)

A ''Yes/No'' Blood Test For Alzheimer's?
For every person with Alzheimer's disease, there are many more--loved ones, healthcare providers, social workers, volunteers, and advocates--whose lives are directly or indirectly touched by this illness. Because the causes of the disease are unknown and there is currently no cure, Alzheimer's poses enormous challenges for physicians and researchers. Therefore, early, definitive detection may ... (Thu, 17 Jan 2008 09:53:16 GMT)

Hopkins Genetics Expert Receives Prestigious Award
A genetics professor at the Johns Hopkins University medical school is being honored with the prestigious Japan Prize in Medical Genetics and Genomics. (Thu, 17 Jan 2008 13:10:59 GMT)

Invitrogen Enters Non-Coding RNA Licensing Agreement with IMBcom
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, has entered into an exclusive license agreement with IMBcom Proprietary Limited Company to commercialize new non-coding ribonucleic acid (RNA) content predicted by a proprietary algorithm and experimentally validated by the University of Queensland, Australia. This ... (Thu, 17 Jan 2008 13:28:08 GMT)

Genetics Expert At Hopkins Receives Award
A genetics professor at the Johns Hopkins University medical school is being honored with the prestigious Japan Prize in Medical Genetics and Genomics. (Thu, 17 Jan 2008 13:32:29 GMT)

Affymetrix to Host Conference Call on January 31, 2008 to Announce Fourth Quarter and Fiscal Year 2007 Results
SANTA CLARA, Calif.----Affymetrix, Inc. today announced that it will release results for the fourth quarter and fiscal year 2007 after close of the stock market on Thursday, January 31, 2008. (Thu, 17 Jan 2008 14:00:00 GMT)

LC/MC Systems enable life science studies.
Available with 32 Gbps DAQ and 20,000 mass resolution, Models 6220 TOF and 6520 Q-TOF LC/MS systems are suited for proteomics, metabolomics, product degradation, and other complex experiments. Model 6520 Q-TOF features attomole sensitivity, better than 2 ppm MS mass accuracy, better than 5 ppm MS/MS mass accuracy, and broad mass range from m/z 25 to 20,000. Model 6220 TOF uses MassHunter ... (Thu, 17 Jan 2008 14:07:30 GMT)

ESF's workshop restores good name of sugar
Sugars were once credited with magical healing powers but are now seen like salt as an evil necessary in small doses but the cause of numerous diseases such as diabetes if taken in excess. Yet latest research suggests this view ignores the vital role played by more complex sugars in many biological structures, and the great therapeutic potential they have. (Thu, 17 Jan 2008 14:08:27 GMT)

CLC bio and Danish Research Institutions Establish Next Generation Sequencing Network
CLC bio and several prominent Danish research institutions have established SEQNET - a national network for developing a unique software platform for the analysis of data from the next generation sequencing technologies. The platform will integrate groundbreaking bioinformatics algorithms with a user-friendly and graphical user interface. The network is funded by the Danish Agency for Science ... (Thu, 17 Jan 2008 14:09:55 GMT)

Blood Test Can Gauge Prostate Cancer Risk, Study Shows
New genomics research has found that a simple blood test can determine which men are likely to develop prostate cancer. Researchers at found that five genetic variants previously associated with prostate cancer risk have a strong cumulative effect. Researchers found that a man with four of the five variants has an increased risk of 400 to 500 percent compared to men with none of the variants. ... (Thu, 17 Jan 2008 15:10:25 GMT)

Chromosomal abnormalities play substantial role in autism
Genome-wide scans of families affected by autism spectrum disorder (ASD) have revealed new evidence that previously unknown chromosomal abnormalities have a substantial role in the prevalent developmental disorder, according to a report published online Jan. 17th in the American Journal of Human Genetics, a publication of Cell Press. (Thu, 17 Jan 2008 17:05:51 GMT)

Genedata Provides Expressionist Platform To Eisai Research Institute
Genedata, a provider of in silico solutions for the pharmaceutical and life sciences industries, today announced an agreement with the Eisai Research Institute (ERI) for the company's Genedata Expressionist biomarker discovery platform (Thu, 17 Jan 2008 17:36:27 GMT)

New Discoveries Confirm and Enhance CombiMatrix's Microarray Test for Autism
MUKILTEO, Wash., Jan. 17, 2008 -- CombiMatrix Corporation announced that today's publication in the American Journal of Human Genetics by Dr. Steve Scherer and colleagues further implicate genomic copy number variation in the etiology of Autism Spectrum Disorder elevating the importance of the CBMX ATScan 1.0 microarray test. (Thu, 17 Jan 2008 18:41:42 GMT)

Closer to Vanquishing the Virus
The field of human genomics is at long last enabling us to focus medical thinking on the infected host. (Thu, 17 Jan 2008 19:10:55 GMT)

New Promega Bioluminescent Assays Provide Greatest Sensitivity for Caspase-2 and -6
Now, scientists have tools that are 100- to 1,000-fold more sensitive than existing assays for caspase-2 and -6. Promega Corporation announces the expansion of bioluminescent caspase assays with the release of Caspase-Glo(R) 2 and 6 Assays that will enable new insights to their physiological roles in apoptosis. (Thu, 17 Jan 2008 21:27:23 GMT)

Restoring The Good Name Of Sugar
Sugars were once credited with magical healing powers but are now seen like salt as an evil necessary in small doses but the cause of numerous diseases such as diabetes if taken in excess. Yet latest research suggests this view ignores the vital role played by more complex sugars in many biological structures, and the great therapeutic potential they have. (Thu, 17 Jan 2008 23:09:44 GMT)

US professor from Maine wins Japanese genetics prize
BAR HARBOUR (Maine) - AN AMERICAN genetics professor is the 2008 recipient of the prestigious Japan Prize in Medical Genetics and Genomics. (Fri, 18 Jan 2008 00:50:42 GMT)

Professor From Maine Wins Genetics Prize
BAR HARBOR (AP) -- A genetics professor from Maine is the 2008 recipient of the prestigious Japan Prize in Medical Genetics and Genomics. (Fri, 18 Jan 2008 01:05:10 GMT)

Professor from Maine wins genetics prize
Victor A. McKusick, a Mainer and longtime genetics professor at John Hopkins University School of Medicine, is the 2008 recipient of the Japan Prize in Medical Genetics and Genomics. (Fri, 18 Jan 2008 03:41:35 GMT)

Archives
UNC recently named Janelle M. Hoskins as the director of the UNC Institute for Pharmacogenomics's new molecular genomics facility. The facility provides project design, data analysis, technology selection and genotyping. (Fri, 18 Jan 2008 07:39:09 GMT)

Cancer - The Right Treatment For The Right Person
There's encouraging news for patients who have been diagnosed with cancer, or who are at risk for developing the disease: A new kind of theranostic technology is helping to determine the nature of the illness at the molecular level, making it possible to customize the course of treatment for patients. (Fri, 18 Jan 2008 10:21:02 GMT)

A ''Yes/No'' Blood Test For Alzheimer's?
For every person with Alzheimer's disease, there are many more-loved ones, healthcare providers, social workers, volunteers, and advocates-whose lives are directly or indirectly touched by this illness. Because the causes of the disease are unknown and there is currently no cure, Alzheimer's poses enormous challenges for physicians and researchers. (Fri, 18 Jan 2008 10:21:22 GMT)

Genizon closes Series E financing of CAD $31m
To fund its personalized medicines and genomic business, Genizon BioSciences decided to close its Series E financing in the amount of CAD $31 million. Genizon has received $130 million since its funding in 1999. (Fri, 18 Jan 2008 12:35:59 GMT)

Genetics Professor Awarded
A genetics professor from Maine is this year's recipient of the prestigious Japan Prize in medical genetics and genomics... The Science and Technology Foundation of Japan announced that Victor McKusick will receive a medal and 50 million Yen, that's about $470,000 (U.S.). (Fri, 18 Jan 2008 12:44:27 GMT)

HIV peptide's possible pathway into cells identified
Washington, January 18 : A pair of theoretical physicists at Rensselaer Polytechnic Institute has searched out a possible pathway that an HIV peptide takes to enter healthy cells. (Fri, 18 Jan 2008 13:04:20 GMT)

Microbial Identification Microarray Tool Identifies 300 Oral Bacterial Species
The Forsyth Institute has launched a new one-of-a-kind service for the research community. The Forsyth Microbial Identification Microarray Service (MIM) enables the rapid identification of bacterial species in clinical samples. The first service offering, Human Oral Microbe Identification Microarray (HOMIM), will focus on detection of bacterial profiles from the oral cavity. (Fri, 18 Jan 2008 13:04:43 GMT)

Glycoscience Now Hotbed Of Medical Research
Sugars were once credited with magical healing powers but are now seen like salt as an evil necessary in small doses but the cause of numerous diseases such as diabetes if taken in excess. Yet latest research suggests this view ignores the vital role played by more complex sugars in many biological structures, and the great therapeutic potential they have. (Fri, 18 Jan 2008 13:07:25 GMT)

Maine scholar receives prize for genetics
BAR HARBOR (AP) - A genetics professor from Maine is the 2008 recipient of the prestigious Japan Prize in Medical Genetics and Genomics. (Fri, 18 Jan 2008 13:31:09 GMT)

HIV Peptide's Possible Pathway Into The Cell Revealed By Researchers
Two theoretical physicists at Rensselaer Polytechnic Institute have uncovered what they believe is the long-sought-after pathway that an HIV peptide takes to enter healthy cells. The theorists analyzed two years of biocomputation and simulation to uncover a surprisingly simple mechanism describing how this protein fragment penetrates the cell membrane. (Fri, 18 Jan 2008 14:05:01 GMT)

Substantial Role In Autism Played By Chromosomal Abnormalities
Genome-wide scans of families affected by autism spectrum disorder (ASD) have revealed new evidence that previously unknown chromosomal abnormalities have a substantial role in the prevalent developmental disorder, according to a report published online Jan. 17th in the American Journal of Human Genetics, a publication of Cell Press. (Fri, 18 Jan 2008 14:05:42 GMT)

HIV's pathway into cells found
WASHINGTON: A pair of theoretical physicists at Rensselaer Polytechnic Institute has searched out a possible pathway that an HIV peptide takes to enter healthy cells. (Fri, 18 Jan 2008 14:25:11 GMT)

Company Profile for Data Shaping Solutions
DataShaping is the leading analytical job board with 500,000 yearly pageviews, consistently ranked #1 according to respected web measurement companies such as Compete.com or Quantcast.com. (Fri, 18 Jan 2008 15:42:37 GMT)

Lussier Names Progenika COO, Fischette Joins Enzo Biochem, McKusick Wins Genomics Prize, and More
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Fri, 18 Jan 2008 19:02:07 GMT)

U.S. geneticist wins Japan Prize
BAR HARBOR, Maine (AP) An American genetics professor is the 2008 recipient of the prestigious Japan Prize in Medical Genetics and Genomics. Read more ... (Fri, 18 Jan 2008 21:19:37 GMT)

Invitrogen and IMBcom sign RNA licensing agreement
Invitrogen has entered into an exclusive license agreement with IMBcom Proprietary Limited Company to commercialize new non-coding ribonucleic acid content, predicted by a proprietary algorithm and experimentally validated by the University of Queensland, Australia. (Sat, 19 Jan 2008 02:28:57 GMT)

With Wii bit of technology, surgeons hone their skills
Trainee surgeons at Banner Good Samaritan Medical Center are hooked on Wii game technology - all the better to sharpen their surgical skills, a new study shows.{v} Nintendo Wii as a surgical training tool (Sat, 19 Jan 2008 07:08:35 GMT)

OncoMethylome licenses several key technologies from Epigenomics
OncoMethylome Sciences S.A. entered into a broad technology licensing agreement with Epigenomics AG. Under the terms of the agreement, OncoMethylome obtained worldwide non-exclusive rights to several of Epigenomics' proprietary core technologies such as its MethyLight portfolio for the sensitive and quantitative detection of DNA methylation for in vitro diagnostic product development and ... (Sat, 19 Jan 2008 09:36:00 GMT)

Noticias Infobolsa / Titulares
James LeVoy Sorenson, who died today, was one of the world s leading . inventors, entrepreneurs and philanthropists. His pioneering inventions - inventors, entrepreneurs and philanthropists. (Sun, 20 Jan 2008 17:14:34 GMT)

James LeVoy Sorenson, World-Renowned Medical Device Inventor, Entrepreneur and Philanthropist, Dies at 86
James LeVoy Sorenson, a globally prominent medical device inventor, entrepreneur and philanthropist, died of cancer today, surrounded by his family. He was 86. (Sun, 20 Jan 2008 17:23:16 GMT)

Inventor, philanthropist James Sorenson, Utah's richest man, dies at 86
James LeVoy Sorenson, whose success as an entrepreneur, real estate magnate and inventor of numerous medical devices made him Utah's richest man, died Sunday, Jan. 20, at a Salt Lake hospital. (Sun, 20 Jan 2008 17:41:35 GMT)

Steps toward Stopping Autoimmune Disease
NEW YORK, January 20, 2008—A landmark genetic study has identified multiple genes linked to systemic lupus erythematosus (SLE), or lupus, a debilitating autoimmune disease that affects an estimated 1.4 million Americans. (Sun, 20 Jan 2008 18:23:27 GMT)

Lupus in women: New genetic risk factors identified
Montreal, January 20, 2008 – An international consortium of clinical scientists and genomics experts, including researchers from the Montreal Heart Institute (MHI) and Université de Montréal (UdeM), have uncovered multiple new genetic risk factors for systemic lupus erythematosus (SLE), commonly known as lupus. (Sun, 20 Jan 2008 18:38:27 GMT)

Gene studies home in on lupus cause
Four separate studies published on Sunday identify a series of genes linked with lupus, a debilitating illness that can affect various parts of the body at once. (Sun, 20 Jan 2008 20:16:32 GMT)

Utah Billionaire Sorenson Dies
James L. Sorenson, who overcame a childhood learning disability and built a fortune in pioneering medical devices and real estate, died of cancer Sunday. He was 86. (Sun, 20 Jan 2008 22:51:40 GMT)

Studies home in on lupus cause
Four separate studies published identify a series of genes linked with lupus, a debilitating illness that can affect various parts of the body at once. (Sun, 20 Jan 2008 22:59:43 GMT)

MBA in finance can prove lucrative
The future looks to be good for MBAs in finance, but more so for those who have qualified from prominent business schools as they get the most prestigious job offers from campus. (Sun, 20 Jan 2008 23:17:10 GMT)

Current state of the art in glycoscience
Sugars were once credited with magical healing powers but are now seen like salt as an evil necessary in small doses but the cause of numerous diseases such as diabetes if taken in excess. (Mon, 21 Jan 2008 00:16:00 GMT)

Previously unknown chromosomal abnormalities play substantial role in autism
Genome-wide scans of families affected by autism spectrum disorder (ASD) have revealed new evidence that previously unknown chromosomal abnormalities have a substantial role in the prevalent developmental disorder, according to a report published online Jan. 17th in the American Journal of Human Genetics, a publication of Cell Press. (Mon, 21 Jan 2008 00:30:50 GMT)

NASA and the X PRIZE Foundation Recognize 2007 Pete Conrad Spirit of Innovation Award Winners
NASA and the X PRIZE Foundation Recognize 2007 Pete Conrad Spirit of Innovation Award Winners (Mon, 21 Jan 2008 04:27:52 GMT)

Cosmic Log: 'I have a genetic dream'
Science editor Alan Boyle's blog: There's been a resurgence of interest in the issue of race - not only because a black man is a serious contender for the presidency, but also because scientific trends have raised new questions about the concept of race. (Mon, 21 Jan 2008 04:45:16 GMT)

Open Classrooms: Millions sampling higher learning on Internet
Berkeley's on YouTube. American University's hoping to get on iTunes. George Mason University professors have created an online research tool, a virtual filing cabinet for scholars. And with a few clicks on Yale's Web site, anyone can watch one of the school's most popular philosophy professors sitting cross-legged on his desk, talking about death. (Mon, 21 Jan 2008 05:19:00 GMT)

Medical Devices Pioneer Sorenson Dies
James L. Sorenson, who overcame a childhood learning disability and built a fortune in pioneering medical devices and real estate, died of cancer Sunday. (Mon, 21 Jan 2008 06:33:00 GMT)

Medical devices pioneer Sorenson dies
James L. Sorenson, who overcame a childhood learning disability and built a fortune in pioneering medical devices and real estate, died of cancer Sunday. He was 86. (Mon, 21 Jan 2008 06:33:09 GMT)

OpenHelix, LLC Receives $1 million NIH Grant to Develop Search and Training Portal for Genomics Resources
Grant funded search tools and tutorials will enable scientists to quickly find and effectively use genomics resources. (Mon, 21 Jan 2008 07:01:00 GMT)

Billionaire James L. Sorenson dies of cancer
Billionaire James L. Sorenson dies of cancer (Mon, 21 Jan 2008 07:16:13 GMT)

Inventor James L. Sorenson dies at 86
James LeVoy Sorenson, whose success as entrepreneur, real estate magnate and inventor of numerous medical devices made him Utah's richest man, died Sunday at a Salt Lake City hospital. (Mon, 21 Jan 2008 08:01:16 GMT)

The life of James LeVoy Sorenson, 1921-2008
1921: Born in Rexburg, Idaho. During Great Depression, family moves to Yuba City, Calif. (Mon, 21 Jan 2008 08:07:07 GMT)

Once ignored, Port St. Lucie now envied for biotechs
Port St. Lucie used to be a passthrough. (Mon, 21 Jan 2008 10:07:06 GMT)

Illumina to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on Monday, February 4, 2008
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2007 following the close of market on Monday, February 4, 2008. (Mon, 21 Jan 2008 11:12:11 GMT)

SSU explores bioinformatics master’s
NORTH BAY – In an effort to help feed the biotechnology job market, officials at Sonoma State University are hoping to launch a new master’s track in the growing field of bioinformatics. (Mon, 21 Jan 2008 11:19:02 GMT)

Sorenson Genomics Founder James Sorenson Dies
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Mon, 21 Jan 2008 15:32:07 GMT)

Researchers identify genetic risk factors linked to lupus
London, Jan 21 : A new study has identified multiple new genetic risk factors for systemic lupus erythematosus (SLE), commonly known as lupus, a debilitating autoimmune disease. (Mon, 21 Jan 2008 15:36:36 GMT)

Phylogeny Named Outstanding Technology Service Company of the Year
Phylogeny, Inc. won the TopCat Award for Outstanding Service Company (less than 50 employees) at TechColumbus' 2007 TopCat Innovation Awards held on January 17, 2008. The annual TopCat Innovation Awards recognize outstanding achievements in technology leadership. (Mon, 21 Jan 2008 17:28:35 GMT)

Medical campus gets design awards
A pair of research laboratory buildings on the Buffalo Niagara Medical Campus have been recognized for their environmentally friendly designs. (Mon, 21 Jan 2008 17:50:40 GMT)

Report: Cincinnati middle of Midwest pack for biomed investment
Ten Cincinnati-area biomedical companies scored $64.6 million in venture capital last year, but that was about one-fifth of what Minneapolis garnered, according to the 2007 Midwest Health Care Venture Investment Report. (Mon, 21 Jan 2008 19:21:57 GMT)

NHGRI Awards OpenHelix $1M To Develop Genomics Training Portal
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Mon, 21 Jan 2008 19:47:16 GMT)

Discovery of multiple genes linked to systemic lupus erythematosus
A landmark genetic study has identified multiple genes linked to systemic lupus erythematosus (SLE), or lupus, a debilitating autoimmune disease that affects an estimated 1.4 million Americans. (Mon, 21 Jan 2008 21:30:52 GMT)

Waters Expands Mass Spectrometry Boundaries with Introduction of Next- Generation, Upgradeable SYNAPT Platform
Waters Corporation today launched the Waters® SYNAPT MS system, a next- generation quadrupole acceleration, time-of-flight mass spectrometry platform. SYNAPT MS is a key part of Waters' strategy to enhance the quality and productivity of life science and drug discovery and development workflows. (Mon, 21 Jan 2008 21:46:00 GMT)

Local News Councillor says sister city exchange is producing results
Councillor Aldo Ruberto said on Monday the sister city initiative between Thunder Bay and Gifu, Japan is beginning to show positive returns for local business interests. (Mon, 21 Jan 2008 22:09:12 GMT)

HIV Peptide's Possible Pathway Into The Cell Revealed
Theoretical physicists have uncovered what they believe is the long-sought-after pathway that an HIV peptide takes to enter healthy cells. The theorists analyzed two years of biocomputation and simulation to uncover a surprisingly simple mechanism describing how this protein fragment penetrates the cell membrane. The discovery could help scientists treat other human illnesses by exploiting the ... (Mon, 21 Jan 2008 23:09:55 GMT)

Chromosomal Abnormalities Play Substantial Role In Autism
Genome-wide scans of families affected by autism spectrum disorder have revealed new evidence that previously unknown chromosomal abnormalities have a substantial role in the prevalent developmental disorder. (Mon, 21 Jan 2008 23:11:05 GMT)

James Sorenson, Medical Device Pioneer, Is Dead at 86
Mr. Sorenson overcame a learning disability and built a fortune in innovative medical devices and real estate. (Tue, 22 Jan 2008 02:11:50 GMT)

Former Ventana Medical VP will head genomics firm here
A former Tucson biotech executive is taking the reins of High Throughput Genomics Inc., the local company was to announce today. (Tue, 22 Jan 2008 07:11:08 GMT)

23andMe(TM) Launches Web-Based Personal Genome Service(TM) Outside U.S., Empowering Individuals to Access and ...
MOUNTAIN VIEW, Calif.----23andMe, Inc., a privately-held personal genetics company, announced today that it has begun making its services available to consumers in Canada and 49 European countries. (Tue, 22 Jan 2008 08:00:00 GMT)

23andMe(TM) Launches Web-Based Personal Genome Service(TM) Outside U.S., Empowering Individuals to Access and ...
23andMe, Inc., a privately-held personal genetics company, announced today that it has begun making its services available to consumers in Canada and 49 European countries. The company, which officially launched in the U.S. on November 16, 2007, helps individuals understand their own genetic information through the latest advances in DNA analysis technologies and web-based interactive tools. (Tue, 22 Jan 2008 08:12:44 GMT)

Major European Project To Create New Knowledge Base Of Gene-Disease Relationships
The 12 Million Euro 'GEN2PHEN' project, funded by the European Commission, aims to harness the web to capture and unify genetic information that fundamentally impacts on a person's health and disease processes. (Tue, 22 Jan 2008 10:20:53 GMT)

LabCorp(R) Announces the Availability of Affymetrix-Based Whole Genome Microarrays
BURLINGTON, N.C.----Laboratory Corporation of America® Holdings is pleased to announce the availability of an ultra high-density microarray, Affymetrix based technology . The offering continues the numerous recent advances in LabCorp's clinical genetics laboratory diagnostics. (Tue, 22 Jan 2008 12:00:00 GMT)

LabCorp(R) Announces the Availability of Affymetrix-Based Whole Genome Microarrays
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) is pleased to announce the availability of an ultra high-density microarray, Affymetrix based technology (Whole-Genome Sampling Analysis). The offering continues the numerous recent advances in LabCorp's clinical genetics laboratory diagnostics. In 2005, LabCorp first offered the comparative genomic hybridization (CGH) based ... (Tue, 22 Jan 2008 12:12:51 GMT)

Rubicon Genomics Enters into Collaboration Agreement with OncoMethylome Sciences
Rubicon Genomics, Inc. today announced a Collaboration Agreement with OncoMethylome Sciences for the identification of biomarkers for early detection of cancer. (Tue, 22 Jan 2008 12:30:00 GMT)

Strategic Diagnostics Announces It Has Surpassed $1 Million in ''Booked'' Genomic Antibody Technology(R) Projects
NEWARK, Del.----Strategic Diagnostics Inc. - today announced that project bookings for "custom" Genomic Antibody Technology® projects exceeded the $1 million dollar mark over the last seven months of 2007. (Tue, 22 Jan 2008 13:00:00 GMT)

Finnish Red Cross Licenses GeneGo Products
GeneGo, Inc., the leading systems biology tools company, announced today that the Finnish Red Cross Blood Service has licensed GeneGo's bioinformatics and chemoinformatics suites MetaCore and MetaDrug, respectively, to be used in a variety of research and clinical projects (Tue, 22 Jan 2008 13:00:00 GMT)

Detailed gene map 'within grasp'
One thousand people around the world are to have their genomes mapped in an effort to understand how genes influence disease. (Tue, 22 Jan 2008 13:05:26 GMT)

International Consortium Announces the 1000 Genomes Project
An international research consortium today announced the 1000 Genomes Project, an ambitious effort that will involve sequencing the genomes of at least 1,000 people from around the world to create the most detailed and medically useful picture to date of human genetic variation. (Tue, 22 Jan 2008 13:06:27 GMT)

International consortium announces the 1000 Genomes Project
An international research consortium today announced the 1000 Genomes Project, an ambitious effort that will involve sequencing the genomes of at least a thousand people from around the world to create the most detailed and medically useful picture to date of human genetic variation. (Tue, 22 Jan 2008 13:10:13 GMT)

International genome project launched
Three-year study will capture variation in 1,000 people. (Tue, 22 Jan 2008 13:12:49 GMT)

Massive new study into how genes affect health
The genetic differences between people are to be mapped in unprecedented detail in the most comprehensive search yet for the inherited roots of common conditions such as diabetes and heart disease. (Tue, 22 Jan 2008 13:56:22 GMT)

Clinical Data, Inc. Strengthens PGxHealth(TM) Leadership with Key Industry Hires
NEWTON, Mass.----Clinical Data, Inc. , a leader in the development of targeted therapeutics and predictive tests from its growing portfolio of proprietary genetic biomarkers, today announced the PGxHeath™ divisional appointments of Meeta Patnaik, MD, as Senior Vice President of Predictive Diagnostics Development and Marcia Lewis, Ph.D., as Vice President of Biomarker Development. (Tue, 22 Jan 2008 14:17:00 GMT)

Knome Commences Whole-Genome Sequencing Process for First Clients
CAMBRIDGE, Mass.----Knome and the Beijing Genomics Institute , announced today that they have initiated the process to sequence the entire genomes of two private individuals. These clients are expected to be the first individuals in the world to have their genome sequenced by a personal genomics firm. (Tue, 22 Jan 2008 14:30:00 GMT)

Giant genome sequencing project announced
A U.S.-British-led international consortium has announced the "1000 Genomes Project" to produce the most detailed map of human genetic variation to date. (Tue, 22 Jan 2008 14:56:09 GMT)

LA BioMed researchers develop new advanced method for measuring protein synthesis
TORRANCE – In a major breakthrough for future research and drug development, a team of Los Angeles Biomedical Research Institute (LA BioMed) investigators developed a new, more reliable method for measuring protein synthesis and turnover, processes that are critical to understanding cellular functions. (Tue, 22 Jan 2008 15:25:17 GMT)

Let a thousand genomes bloom
Genetic researchers in China, Britain and the United States are teaming up to unravel the full genetic code of at least 1,000 people around the world. (Tue, 22 Jan 2008 15:30:17 GMT)

First SC072 Catapult Installed at Rutgers
SiCortex, the emerging leader in compact, low power Linux(R) clusters, announced today that the first SC072 Catapult personal cluster was shipped to Professors Gyan Bhanot and Manish Parashar at Rutgers University. The 72-processor deskside unit, which was named the industry's sexiest product by ZDnet at the Supercomputing 07 conference in November, will be used to develop a new computer science ... (Tue, 22 Jan 2008 16:17:19 GMT)

Story ideas from Molecular and Cellular Proteomics
Graph displaying the range of biological variation of the platelet proteome overlaid on a colored 2D-gel used to measure platelet protein expression. (Tue, 22 Jan 2008 16:53:55 GMT)

International consortium announces the 1000 Genomes Project
An international research consortium today announced the 1000 Genomes Project, an ambitious effort to sequence the genomes of at least 1,000 people to create the most detailed and medically useful catalogue to date of human genetic variation. (Tue, 22 Jan 2008 16:54:05 GMT)

Project Will Map Genomes of 1,000 People Worldwide
TUESDAY, Jan. 22 (HealthDay News) -- The genomes of 1,000 people worldwide will be mapped in what scientists are calling the most detailed and medically relevant look at human genetic variation ever conducted. (Tue, 22 Jan 2008 17:02:15 GMT)

Searching for Amyloid Interactions
Researchers have undertaken a large-scale investigation into the molecular environment of the amyloid precursor protein (APP), a protein centrally associated with Alzheimer's disease. (Tue, 22 Jan 2008 17:21:29 GMT)

Low Variation in Platelet Protein Expression within the Elderly
The variation in human platelets in the elderly population is not significantly large, report researchers in a study that has strong implications for clinical biomarker research. (Tue, 22 Jan 2008 17:21:39 GMT)

Plexera Bioscience Ships First Plexera(TM) K(X)5 Analyzer to Early Access Partner
BOTHELL, Wash.----Plexera Bioscience LLC, a wholly owned subsidiary of Lumera Corporation , announced today that it has shipped a pre-commercial version of its novel Plexera™ KX5 Analyzer. (Tue, 22 Jan 2008 17:51:00 GMT)

Method for detecting cancer and a method for suppressing cancer
An object of the invention is to find a cancer-associated gene to be used as an index for detecting canceration of cells and degree of malignancy of cancer, so as to (Tue, 22 Jan 2008 18:00:48 GMT)

Project to map DNA of 1,000 people
An international consortium of scientists plans to study the genomes of 1,000 people in an effort to speed up the diagnosis and treatment of some common diseases. (Tue, 22 Jan 2008 18:07:05 GMT)

Plexera Bioscience Ships First Plexera(TM) K(X)5 Analyzer to Early Access Partner
Plexera Bioscience LLC, a wholly owned subsidiary of Lumera Corporation (NASDAQ:LMRA), announced today that it has shipped a pre-commercial version of its novel Plexera(TM) K(X)5 Analyzer. Plexera's first Early Access Partner is a pharmaceutical company who will be evaluating the system as a tool for screening and characterizing antibody libraries. As part of the early access agreement, the ... (Tue, 22 Jan 2008 18:12:31 GMT)

Project Will Map Genomes of 1,000 People Worldwide
International effort should spot genes that help cause disease, scientists say (Tue, 22 Jan 2008 19:46:52 GMT)

Penn Genomics Institute Changes Name, Will Emphasize Interdisciplinary Genomics
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 22 Jan 2008 20:47:17 GMT)

International effort to catalog complete DNA of 1,000 people
Researchers on three continents will join together to catalog the genomes of 1,000 people in an ambitious project that they hope will help determine genetic roots and factors for human disease, the group announced Tuesday. (Tue, 22 Jan 2008 20:53:30 GMT)

Global project to map DNA of 1,000 people
Scientists plan to map the DNA of 1,000 people worldwide to examine human genetic variation. (Tue, 22 Jan 2008 21:24:39 GMT)

Genetics Influence Blood Pressure Medications
TUESDAY, Jan. 22 (HealthDay News) -- A person's genetic make-up seems to influence how he or she reacts to certain hypertension medications. (Tue, 22 Jan 2008 22:02:33 GMT)

Global effort to record complete DNA of 1,000 people
WASHINGTON - RESEARCHERS on three continents will join together to catalogue the genomes of 1,000 people in an ambitious project that they hope will help determine genetic roots and factors for human disease, the group announced on Tuesday. (Tue, 22 Jan 2008 23:06:03 GMT)

Researchers launch 1000 Genomes Project
Researchers from England's Wellcome Trust Sanger Institute, the US National Human Genome Research Institute (NHGRI), and China's Beijing Genomics Institute-Shenzhen are going to launch the 1000 Genomes Project in order to get the most detailed data on DNA and try to find out the genetic root of human disease. (Tue, 22 Jan 2008 23:59:07 GMT)

Project aims to map DNA of 1,000 people
Any two people may be roughly 99 percent identical at the genetic level. But the small differences are what tantalize scientists, and now they plan to map the DNA of 1,000 people worldwide to examine human genetic variation. (Wed, 23 Jan 2008 01:50:15 GMT)

Rubicon collaborates with OncoMethylome in cancer detection
Rubicon Genomics has signed a collaboration agreement with OncoMethylome Sciences for the identification of biomarkers for early detection of cancer. (Wed, 23 Jan 2008 02:27:57 GMT)

Cancer Claims Billionaire Inventor Sorenson
Dyslexic built a huge fortune with medical inventions. (Wed, 23 Jan 2008 03:40:50 GMT)

DNA-Based Artificial Nose
Single-stranded DNA can be used to identify explosives and other airborne compounds. (Wed, 23 Jan 2008 05:01:55 GMT)

A foreign experience
On the first day of her freshman year in September 2006, LSA sophomore Erina Uozumi traveled from El Salvador to arrive on the doorstep of East Quad, the home of the University of Michigan's Residential College and the college's notoriously quirky residents. (Wed, 23 Jan 2008 09:11:46 GMT)

Major Sequencing Effort Will Produce Most Detailed Map Of Human Genetic Variation To Support Disease Studies
An international research consortium has announced the 1000 Genomes Project, an ambitious effort that will involve sequencing the genomes of at least a thousand people from around the world to create the most detailed and medically useful picture to date of human genetic variation. (Wed, 23 Jan 2008 10:21:32 GMT)

Illumina Announces Multi-Million Dollar Agreement with Erasmus Medical Center
SAN DIEGO----Illumina today announced that Erasmus Medical Center in Rotterdam has purchased Infinium HD Human610-Quad BeadChips for the analysis of 10,000 samples and a third scanner to support the Generation R Study. (Wed, 23 Jan 2008 11:00:00 GMT)

News From Molecular And Cellular Proteomics
Searching for Amyloid InteractionsResearchers have undertaken a large-scale investigation into the molecular environment of the amyloid precursor protein (APP), a protein centrally associated with Alzheimer's disease.A defining hallmark of Alzheimer's is the extracellular accumulation of amyloid plaques in the diseased brain. (Wed, 23 Jan 2008 11:05:12 GMT)

Illumina Announces Multi-Million Dollar Agreement with Erasmus Medical Center
Illumina (NASDAQ: ILMN) today announced that Erasmus Medical Center in Rotterdam has purchased Infinium HD (High-Density) Human610-Quad BeadChips for the analysis of 10,000 samples and a third scanner to support the Generation R Study. Designed to identify early environmental and genetic causes of normal and abnormal growth, development, and health from fetal life until young adulthood, the ... (Wed, 23 Jan 2008 11:28:21 GMT)

JIC tooled up for crop job
Vital genetic tools to enhance crop science are being made available to the John Innes Centre in Norwich by a Wall Street quoted company. (Wed, 23 Jan 2008 11:54:23 GMT)

LA BioMed Researchers Develop New, More Reliable Method For Measuring Protein Synthesis
In a major breakthrough for future research and drug development, a team of Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) investigators developed a new, more reliable method for measuring protein synthesis and turnover, processes that are critical to understanding cellular functions. (Wed, 23 Jan 2008 12:06:12 GMT)

Waters' Synapt Mass Spectrometry to hasten drug discovery
Waters, the lab instrumentation major, has launched Synapt Mass Spectrometry (MS) system in India which can hasten drug discovery efforts at the research labs of pharma and biotech companies. (Wed, 23 Jan 2008 12:20:55 GMT)

Gene genies step up war against killer diseases
Scientists plan to land a $50 million pre-emptive strike on some of the world’s biggest killer diseases under an ambitious international gene sequencing collaboration led out of Cambridge. (Wed, 23 Jan 2008 12:39:27 GMT)

Seventh Annual Five Ventures(R) Business Plan Competition Underway at www.Five-Ventures.com
Five Ventures(R) has announced the launch of the seventh annual business plan competition and conference at UNC Charlotte, featuring a new website and larger purse. (Wed, 23 Jan 2008 12:45:20 GMT)

Michael L. Salgaller, Ph.D., Appointed Chief Operating Officer of Calibrant Biosystems
GAITHERSBURG, Md.----Calibrant Biosystems, a biotechnology company specializing in proteomics, today announced the appointment of Dr. Michael Salgaller as its Chief Operating Officer, effectively immediately. (Wed, 23 Jan 2008 12:58:00 GMT)

International Consortium Announces the 1000 Genomes Project
Major Sequencing Effort Will Produce the Most Detailed Map of Human Genetic Variation to Support Disease Studies (Wed, 23 Jan 2008 13:21:59 GMT)

1000 genomes sequencing project announced
Washington, Jan 23 : An international research association has announced the 1000 Genomes Project on Jan 23. (Wed, 23 Jan 2008 13:52:38 GMT)

Transgenomic Appoints Dr. Eric Kaldjian as Chief Scientific Officer
Transgenomic, Inc. , today announced that Eric Kaldjian, M.D. has joined its executive management team as Chief Scientific Officer. (Wed, 23 Jan 2008 15:09:00 GMT)

Luminex & Tyson Foods Sign Collaboration Agreement
Luminex Corporation (NASDAQ: LMNX) and Tyson Foods, Inc. (NYSE: TSN) have reached a collaboration agreement, to create faster, more accurate and cost-effective food safety and animal health tests, the two companies announced today. (Wed, 23 Jan 2008 15:33:21 GMT)

The Center for Molecular Medicine Doubles Lab Staff, Expands Lab Space by 100 Percent
The Center for Molecular Medicine today announced the hiring of two medical technologists and a scientist to support the expansion of the laboratory's clinical test menu and genomics services offerings. (Wed, 23 Jan 2008 16:07:00 GMT)

1000 Genomes: Most Detailed Map Of Human Genetic Variation To Support Disease Studies
An international research consortium today announced the 1000 Genomes Project, an ambitious effort that will involve sequencing the genomes of at least a thousand people from around the world to create the most detailed and medically useful picture to date of human genetic variation. (Wed, 23 Jan 2008 16:24:34 GMT)

JVIC receives first corporate gift
Missouri State University's Roy Blunt Jordan Valley Innovation Center (JVIC) announced today its first corporate gift, a $125,000 donation from the Bank of America Charitable Foundation. The grant will enhance the state-of-the-art JVIC by funding the construction of an electromagnetic device fabrication laboratory. "In a relatively short period of time, JVIC has spawned redevelopment efforts in ... (Wed, 23 Jan 2008 17:38:45 GMT)

Luminex Corporation Fourth Quarter and Year-End 2007 Earnings Release Scheduled for February 7, 2008
Luminex Corporation (NASDAQ:LMNX) today announced that it expects to report fourth quarter and year-end 2007 results on Thursday, February 7, 2008. Results are scheduled for release after the close of trading. (Wed, 23 Jan 2008 17:44:21 GMT)

Ampersand Ventures Invests in Signature Genomic Laboratories
SPOKANE, Wash.----Ampersand Ventures, a private equity firm focusing on investments in the health care and industrial technology sectors, has acquired a stake in Signature Genomic Laboratories, LLC. (Wed, 23 Jan 2008 17:52:00 GMT)

Previous 1 2 3 4 5 Next